HCN4
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
Also known as: HCN4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y3Q4
- Gene
- HCN4
- Ensembl
- ENSG00000138622
- Chromosome
- 15
- Canonical length
- 1203 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes a member of the hyperpolarization-activated cyclic nucleotide-gated potassium channels. The encoded protein shows slow kinetics of activation and inactivation, and is necessary for the cardiac pacemaking process. This channel may also mediate responses to sour stimuli. Mutations in this gene have been linked to sick sinus syndrome 2, also known as atrial fibrillation with bradyarrhythmia or familial sinus bradycardia. Two pseudogenes have been identified on chromosome 15. [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
1203 residues, UniProt reviewed canonical sequence.
>Q9Y3Q4|HCN4
1 MDKLPPSMRK RLYSLPQQVG AKAWIMDEEE DAEEEGAGGR QDPSRRSIRL RPLPSPSPSA
61 AAGGTESRSS ALGAADSEGP ARGAGKSSTN GDCRRFRGSL ASLGSRGGGS GGTGSGSSHG
121 HLHDSAEERR LIAEGDASPG EDRTPPGLAA EPERPGASAQ PAASPPPPQQ PPQPASASCE
181 QPSVDTAIKV EGGAAAGDQI LPEAEVRLGQ AGFMQRQFGA MLQPGVNKFS LRMFGSQKAV
241 EREQERVKSA GFWIIHPYSD FRFYWDLTML LLMVGNLIII PVGITFFKDE NTTPWIVFNV
301 VSDTFFLIDL VLNFRTGIVV EDNTEIILDP QRIKMKYLKS WFMVDFISSI PVDYIFLIVE
361 TRIDSEVYKT ARALRIVRFT KILSLLRLLR LSRLIRYIHQ WEEIFHMTYD LASAVVRIVN
421 LIGMMLLLCH WDGCLQFLVP MLQDFPDDCW VSINNMVNNS WGKQYSYALF KAMSHMLCIG
481 YGRQAPVGMS DVWLTMLSMI VGATCYAMFI GHATALIQSL DSSRRQYQEK YKQVEQYMSF
541 HKLPPDTRQR IHDYYEHRYQ GKMFDEESIL GELSEPLREE IINFNCRKLV ASMPLFANAD
601 PNFVTSMLTK LRFEVFQPGD YIIREGTIGK KMYFIQHGVV SVLTKGNKET KLADGSYFGE
661 ICLLTRGRRT ASVRADTYCR LYSLSVDNFN EVLEEYPMMR RAFETVALDR LDRIGKKNSI
721 LLHKVQHDLN SGVFNYQENE IIQQIVQHDR EMAHCAHRVQ AAASATPTPT PVIWTPLIQA
781 PLQAAAATTS VAIALTHHPR LPAAIFRPPP GSGLGNLGAG QTPRHLKRLQ SLIPSALGSA
841 SPASSPSQVD TPSSSSFHIQ QLAGFSAPAG LSPLLPSSSS SPPPGACGSP SAPTPSAGVA
901 ATTIAGFGHF HKALGGSLSS SDSPLLTPLQ PGARSPQAAQ PSPAPPGARG GLGLPEHFLP
961 PPPSSRSPSS SPGQLGQPPG ELSLGLATGP LSTPETPPRQ PEPPSLVAGA SGGASPVGFT
1021 PRGGLSPPGH SPGPPRTFPS APPRASGSHG SLLLPPASSP PPPQVPQRRG TPPLTPGRLT
1081 QDLKLISASQ PALPQDGAQT LRRASPHSSG ESMAAFPLFP RAGGGSGGSG SSGGLGPPGR
1141 PYGAIPGQHV TLPRKTSSGS LPPPLSLFGA RATSSGGPPL TAGPQREPGA RPEPVRSKLP
1201 SNLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HCN4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 8.2 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 8.2 nTPM
- testis: 7 nTPM
- hypothalamus: 1.2 nTPM
- midbrain: 1 nTPM
- cerebral cortex: 0.8 nTPM
- amygdala: 0.6 nTPM
Single-cell type
- late spermatids: 83 nCPM
- early spermatids: 45 nCPM
- gonadotrophs: 9.2 nCPM
- other brain neurons: 9.1 nCPM
- respiratory ciliated cells: 8.3 nCPM
- late primary spermatocytes: 7.8 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 22 nTPM
- pons: 14 nTPM
- midbrain: 12 nTPM
- amygdala: 11 nTPM
- hypothalamus: 9.3 nTPM
- medulla oblongata: 8.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HCN4.
Disease | AllUniProt
Conditions HCN4 is implicated in, by any mechanism.
- Sick sinus syndrome 2 (SSS2) MIM:163800
- Brugada syndrome 8 (BRGDA8) MIM:613123
- Epilepsy, idiopathic generalized 18 (EIG18) MIM:619521
Disease | GeneticClinVar
21 pathogenic / likely-pathogenic of 2,256 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Brugada syndrome 8
- Sick sinus syndrome 2, autosomal dominant
- Cardiovascular phenotype
- Left ventricular noncompaction cardiomyopathy
- HCN4-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.24
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.75
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood circulation
- cellular response to cAMP
- cellular response to cGMP
- membrane depolarization during cardiac muscle cell action potential
- membrane depolarization during SA node cell action potential
- monoatomic cation transport
- muscle contraction
- potassium ion import across plasma membrane
- potassium ion transmembrane transport
- regulation of cardiac muscle cell action potential involved in regulation of contraction
- regulation of cardiac muscle contraction
- regulation of heart rate
- regulation of heart rate by cardiac conduction
- regulation of membrane depolarization
- regulation of membrane potential
- regulation of SA node cell action potential
- SA node cell action potential
- sinoatrial node development
- sodium ion import across plasma membrane
- sodium ion transmembrane transport
Molecular functions
- cAMP binding
- identical protein binding
- intracellularly cAMP-activated cation channel activity
- voltage-gated potassium channel activity
- voltage-gated sodium channel activity
- voltage-gated potassium channel activity involved in SA node cell action potential depolarization
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cyclic nucleotide-binding domain
- Potassium channel, voltage-dependent, EAG/ELK/ERG-like
- Ion transport domain
- Ion transport N-terminal
- RmlC-like jelly roll fold
- Cyclic nucleotide-binding, conserved site
- Cyclic nucleotide-binding domain superfamily
- Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel
- Cyclic nucleotide-binding domain
- Ion transport protein
- Ion transport protein N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HCN4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HCN4 as an antibody target. Whether an autoantibody or antibody against HCN4 could matter depends on whether native HCN4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HCN4 is annotated at the cell surface, where native HCN4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label HCN4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...